Aromatic compositions as inhibitors of exoprotein production in non-absorbent articles
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61F-009/00
A61F-013/15
A01N-025/34
출원번호
US-0803345
(2004-03-18)
등록번호
US-7258867
(2007-08-21)
발명자
/ 주소
Syverson,Rae Ellen
Proctor,Richard A.
출원인 / 주소
Kimberly Clark Worldwide, Inc.
대리인 / 주소
Senniger Powers
인용정보
피인용 횟수 :
0인용 특허 :
57
초록▼
Non-absorbent articles are disclosed. The non-absorbent articles include an effective amount of an aromatic inhibitory compound to substantially inhibit the production of exotoxins by Gram positive bacteria. The aromatic inhibitory compounds of the present invention have the general formula: wher
Non-absorbent articles are disclosed. The non-absorbent articles include an effective amount of an aromatic inhibitory compound to substantially inhibit the production of exotoxins by Gram positive bacteria. The aromatic inhibitory compounds of the present invention have the general formula: wherein R1 is selected from the group consisting of H, and NH2 and salts thereof; R5 is a monovalent saturated or unsaturated aliphatic hydrocarbyl moiety; R6 is a divalent saturated or unsaturated aliphatic hydrocarbyl moiety; R7 is a trivalent saturated or unsaturated aliphatic hydrocarbyl moiety; R8 is a monovalent substituted or unsubstituted saturated or unsaturated aliphatic hydrocarbyl moiety which may or may not be interrupted with hetero atoms; R2, R3, and R4 are independently selected from the group consisting of H, OH, COOH, and--C(O)R9; R9 is hydrogen or a monovalent saturated or unsaturated aliphatic hydrocarbyl moiety.
대표청구항▼
What is claimed is: 1. An exoprotein inhibitor for inhibiting the production of exoproteins from Gram positive bacteria in and around the vagina comprising a non-absorbent substrate for insertion into a vagina being selected from the group consisting of a non-absorbent incontinence device, a barrie
What is claimed is: 1. An exoprotein inhibitor for inhibiting the production of exoproteins from Gram positive bacteria in and around the vagina comprising a non-absorbent substrate for insertion into a vagina being selected from the group consisting of a non-absorbent incontinence device, a barrier birth control device, a tampon applicator, and a douche, the non-absorbent substrate having deposited thereon an effective amount of a first active ingredient, an effective amount of a second active ingredient, and a pharmaceutically active material selected from the group consisting of antimicrobials, antioxidants, anti-parasitic agents, antipruritics, astringents, local anaesthetics, and anti-inflammatory agents, the first active ingredient having the general formula: wherein R1 is selected from the group consisting of H,--C(O)NH2 and salts thereof; R5 is a monovalent saturated or unsaturated aliphatic hydrocarbyl moiety; R6 is a divalent saturated or unsaturated aliphatic hydrocarbyl moiety; R7 is a trivalent saturated or unsaturated aliphatic hydrocarbyl moiety; R8 is a monovalent substituted or unsubstituted saturated or unsaturated aliphatic hydrocarbyl moiety which may or may not be interrupted with hetero atoms; R2, R3, and R4 are independently selected from the group consisting of H, OH, COOH, and--C(O)R9; R9 is hydrogen or a monovalent saturated or unsaturated aliphatic hydrocarbyl moiety, the second active ingredient having the general formula: description="In-line Formulae" end="lead"R10--O--R11description="In-line Formulae" end="tail" wherein R10 is a straight or branched alkyl or straight or branched alkenyl having from 8 to about 18 carbon atoms and R11 is selected from the group consisting of an alcohol, a polyalkoxylated sulfosuccinate salt, and wherein the first active ingredient and the second active ingredient are effective in inhibiting the production of exoprotein from Gram positive bacteria. 2. An exoprotein inhibitor for inhibiting the production of exoproteins from Gram positive bacteria in and around the vagina comprising a non-absorbent substrate for insertion into a vagina being selected from the group consisting of a non-absorbent incontinence device, a barrier birth control device, a tampon applicator, and a douche, the non-absorbent substrate having deposited thereon an effective amount of a first active ingredient and an effective amount of a second active ingredient, the first active ingredient having the general formula: wherein R1 is selected from the group consisting of H,--C(O)NH2 and salts thereof; R5 is a monovalent saturated or unsaturated aliphatic hydrocarbyl moiety; R6 is a divalent saturated or unsaturated aliphatic hydrocarbyl moiety; R7 is a trivalent saturated or unsaturated aliphatic hydrocarbyl moiety; R8 is a monovalent substituted or unsubstituted saturated or unsaturated aliphatic hydrocarbyl moiety which may or may not be interrupted with hetero atoms; R2, R3, and R4 are independently selected from the group consisting of H, OH, COOH, and--C(O)R9; R9 is hydrogen or a monovalent saturated or unsaturated aliphatic hydrocarbyl moiety, wherein the first active ingredient is effective in inhibiting the production of exoprotein from Gram positive bacteria, and the second active ingredient comprising an alkyl polyglycoside effective in substantially inhibiting the production of exoprotein from Gram positive bacteria. 3. The exoprotein inhibitor as set forth in claim 2 wherein the alkyl polyglycoside has an alkyl group having from about 8 to about 18 carbon atoms. 4. The exoprotein inhibitor as set forth in claim 3 wherein the alkyl group is a linear alkyl group. 5. The exoprotein inhibitor as set forth in claim 3 wherein the alkyl polyglycoside has an alkyl group having from about 8 to about 14 carbon atoms. 6. The exoprotein inhibitor as set forth in claim 2 wherein the alkyl polyglycoside has an HLB of 12 to 14. 7. The exoprotein inhibitor as set forth in claim 2 wherein the alkyl polyglycoside has an HLB of 10 to 15. 8. The exoprotein inhibitor as set forth in claim 2 wherein the alkyl polyglycoside has the general formula: description="In-line Formulae" end="lead"H--(Zn)--O--R14description="In-line Formulae" end="tail" wherein Z is a saccharide residue having 5 or 6 carbon atoms, n is a whole number from 1 to 6, and R14 is a linear alkyl group having from about 8 to about 18 carbon atoms. 9. The exoprotein inhibitor as set forth in claim 8 wherein R14 is a linear alkyl group having from about 8 to about 14 carbon atoms. 10. The exoprotein inhibitor as set forth in claim 8 wherein R14 is a linear alkyl group having from about 8 to about 12 carbon atoms. 11. The exoprotein inhibitor as set forth in claim 2 wherein the second active ingredient is present in an amount of at least about 0.0001 millimoles per gram of non-absorbent substrate. 12. The exoprotein inhibitor as set forth in claim 2 wherein the second active ingredient is present in an amount of at least about 0.005 millimoles per gram of non-absorbent substrate. 13. The exoprotein inhibitor as set forth in claim 2 wherein the second active ingredient is present in an amount of at least about 0.005 millimoles per gram of non-absorbent substrate to about 2 millimoles per gram of non-absorbent substrate. 14. An exoprotein inhibitor for inhibiting the production of exoproteins from Gram positive bacteria in and around the vagina comprising a non-absorbent substrate for insertion into a vagina being selected from the group consisting of a non-absorbent incontinence device, a barrier birth control device, a tampon applicator, and a douche, the non-absorbent substrate having deposited thereon an effective amount of a first active ingredient and an effective amount of a second active ingredient, the first active ingredient having the general formula: wherein R1 is selected from the group consisting of H,--C(O)NH2 and salts thereof; R5 is a monovalent saturated or unsaturated aliphatic hydrocarbyl moiety; R6 is a divalent saturated or unsaturated aliphatic hydrocarbyl moiety; R7 is a trivalent saturated or unsaturated aliphatic hydrocarbyl moiety; R8 is a monovalent substituted or unsubstituted saturated or unsaturated aliphatic hydrocarbyl moiety which may or may not be interrupted with hetero atoms; R2, R3, and R4 are independently selected from the group consisting of H, OH, COOH, and--C(O)R9; R9 is hydrogen or a monovalent saturated or unsaturated aliphatic hydrocarbyl moiety, wherein the first active ingredient is effective in inhibiting the production of exoprotein from Gram positive bacteria, the second active ingredient being selected from the group consisting of glycerol monolaurate and myreth-3-myristate wherein said second active ingredient is effective in substantially inhibiting the production of exoprotein from Gram positive bacteria. 15. An exoprotein inhibitor for inhibiting the production of exoproteins from Gram positive bacteria in and around the vagina comprising a non-absorbent substrate for insertion into a vagina being selected from the group consisting of a non-absorbent incontinence device, a barrier birth control device, a tampon applicator, and a douche, the non-absorbent substrate having deposited thereon an effective amount of a first active ingredient and an effective amount of a second active ingredient, the first active ingredient having the general formula: wherein R1 is selected from the group consisting of H,--C(O)NH2 and salts thereof; R5 is a monovalent saturated or unsaturated aliphatic hydrocarbyl moiety; R6 is a divalent saturated or unsaturated aliphatic hydrocarbyl moiety; R7 is a trivalent saturated or unsaturated aliphatic hydrocarbyl moiety; R8 is a monovalent substituted or unsubstituted saturated or unsaturated aliphatic hydrocarbyl moiety which may or may not be interrupted with hetero atoms; R2, R3, and R4 are independently selected from the group consisting of H, OH, COOH, and--C(O)R9; R9 is hydrogen or a monovalent saturated or unsaturated aliphatic hydrocarbyl moiety, wherein the first active ingredient is effective in inhibiting the production of exoprotein from Gram positive bacteria, and the second active ingredient having the general formula: wherein R23 is an alkyl group having from 8 to about 18 carbon atoms and R24, R25, and R26 are independently selected from the group consisting of hydrogen and alkyl group having from 1 to about 18 carbon atoms and which can have one or more substitutional moieties selected from the group consisting of hydroxyl, carboxyl, carboxyl salts, and imidazoline wherein the second active ingredient is effective in substantially inhibiting the production of exoprotein from Gram positive bacteria. 16. The exoprotein inhibitor as set forth in claim 15 wherein the second active ingredient is triethanolamide laureth sulfate. 17. The exoprotein inhibitor as set forth in claim 15 wherein the second active ingredient is present in an amount of at least about 0.0001 millimoles per gram of non-absorbent substrate. 18. The exoprotein inhibitor as set forth in claim 15 wherein the second active ingredient is present in an amount of at least about 0.005 millimoles per gram of non-absorbent substrate. 19. The exoprotein inhibitor as set forth in claim 15 wherein the second active ingredient is present in an amount from about 0.005 millimoles per gram of non-absorbent substrate to about 0.2 millimoles per gram of non-absorbent substrate. 20. The exoprotein inhibitor as set forth in claim 15 further comprising a pharmaceutically active material selected from the group consisting of antimicrobials, antioxidants, anti-parasitic agents, antipruritics, astringents, local anaesthetics and anti-inflammatory agents.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (57)
Krautkramer Candace Dyan ; Everett Rob David ; LeMinh Toan Thanh ; McDowall Debra Jean ; Wilhelm Hoa La ; Zenker David Louis, Absorbent product containing an elastic absorbent component.
Fendler Eleanor J. ; Williams Ronald A. ; Dolan Michael J., Antimicrobial cleansing composition containing chlorhexidine, an amphoteric surfactant, and an alkyl polyglucoside.
Beerse Peter William ; Biedermann Kimberly Ann ; Page Steven Hardy ; Mobley Michael Joseph ; Morgan Jeffrey Michael, Antimicrobial compositions comprising a benzoic acid analog and a metal salt.
Jacob Joseph (100 Miller Lake Rd. Wooster OH 44691) Lau John R. (1634 Morgan St. Wooster OH 44691) Geho W. Blair (533 Beechwood St. Wooster OH 44691), Antitoxin vaginal products and catamenials.
Leveen Harry H. (321 Confederate Cir. Charleston SC 29407) Leveen Robert F. (312 Lombard St. Philadelphia PA 19147) Leveen Eric G. (19 Palmetto Rd. Charleston SC 29407), Contraceptive sponge and tampon.
Hoppe Udo,DEX ; Liebl Martina,DEX ; Sauermann Gerhard,DEX ; Traupe Bernd,DEX ; Wolf Florian,DEX, Deodorizing and anti-microbial compositions for use in cosmetic or topical preparations.
Merida A. D'Augustine ; James H. Liu ; Donald C. Harrison, Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections.
Yahiaoui Ali ; Ning Xin ; Bolian ; II Charles Edward ; McDowall Debra Jean ; Potts David Charles ; VanHout Daniel Joseph, Durable hydrophilic coating for a porous hydrophobic polymer substrate.
Yahiaoui Ali ; Ning Xin ; Bolian ; II Charles Edward ; McDowall Debra Jean ; Potts David Charles ; VanHout Daniel Joseph, Durable hydrophilic coating for a porous hydrophobic substrate.
Boney Lee Cullen ; Borders Richard Arnold ; Di Luccio Robert Cosmo ; Kepner Eric Scott ; Yahiaoui Ali, Enhanced odor absorption by natural and synthetic polymers.
LeVeen Harry H. (321 Confederate Cir. Charleston) LeVeen Eric G. (19 Palmetto Rd. Charleston SC 29407) LeVeen Robert F. (312 Lombard St. Philadelphia PA 19147), Iodine contraceptive sponge.
Yahiaoui Ali (2003 Harbour Landing Roswell GA 30076) Potts David C. (5268 Wynterhall Ct. Dunwoody GA 30338) Perkins Cheryl A. (4977 Farihaven Way Roswell GA 30075) Powers Michael D. (813 Vinson Ct. W, Porous non-woven bovine blood-oxalate absorbent structure.
von Bittera Miklos (Leverkusen DEX) Bchel Karl H. (Burscheid DEX) Plempel Manfred (Wuppertal DEX) Regel Erik (Wuppertal DEX), Process for production of vaginal tampons containing pharmaceutical active compound.
Silber Arthur L. (543 Dobbins Ave. San Gabriel CA 91775) Ng Raymond C. (1737 Oak Grove San Marino CA 91108) Caillouette James C. (685 Oak Knoll Cir. Pasadena CA 91106), Toxicity resistant tampon structure.
Yahiaoui Ali ; Lindon Jack Nelson ; Garavaglia Arthur Edward ; Leach Crystal Sutphin ; Hetzler Connie Lynn ; Woltman Garry Roland ; Potts David Charles, Treatment of materials to improve handling of viscoelastic fluids.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.